Bioventus (BVS) EBITDA Margin Growth (1y) (2021 - 2026)
Bioventus (BVS) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 241.00 |
| 10 | Bioventus | 824.72 Mn | 788.87 Mn | 90.77 Mn | 244.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 244.00 |
| Dec 31, 2025 | 733.00 |
| Sep 27, 2025 | 549.00 |
| Jun 28, 2025 | 3,325.00 |
| Mar 29, 2025 | 12.00 |
| Dec 31, 2024 | 415.00 |
| Sep 28, 2024 | 62.00 |
| Jun 29, 2024 | -2,574.00 |
| Mar 30, 2024 | 8,113.00 |
| Dec 31, 2023 | 1,329.00 |
| Sep 30, 2023 | 10,058.00 |
| Jul 1, 2023 | 728.00 |
| Apr 1, 2023 | -5,903.00 |
| Dec 31, 2022 | -1,001.00 |
| Oct 1, 2022 | -9,762.00 |
| Jul 2, 2022 | 287.00 |
| Apr 2, 2022 | -4,519.00 |
| Dec 31, 2021 | -841.00 |
| Oct 2, 2021 | -903.00 |
| Jul 3, 2021 | 269.00 |